Product Information
DOVATO 50-300 MG TABLET is a brand product labeled by ViiV Healthcare Company, priced at $105.2551 per EA under NDC 49702024633. Its NADAC has been published 125 times since Feb 7, 2024.
Strength
50; 300 mg/1; mg/1
Manufacturer
ViiV Healthcare CompanyNDC
49702024633
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DOLUTEGRAVIR SODIUM; LAMIVUDINEApproval Type
New Drug (NDA)
FDA Application
NDA211994On Market Since
4/8/2019
Pharmacological Classes
Price Statistics
The NADAC for DOVATO 50-300 MG TABLET has been published 125 times since Feb 7, 2024, and over the history we have for it it has risen 9.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $105.2551 per EA |
|---|---|
| All-time high | $105.2874 (May 13, 2026) |
| All-time low | $96.0750 (Feb 7, 2024) |
| 52-week high | $105.2874 |
| 52-week low | $99.9590 |
| Median price | $99.9787 |
| Average price | $99.6314 |
| Largest weekly change | +5.0% (Jan 7, 2026) |
| Weeks tracked | 125 |
| Tracking since | Feb 7, 2024 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DOVATO 50-300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DOVATO 50-300 MG TABLET, manufactured by ViiV Healthcare Company, is $105.2551 per EA (NDC 49702024633), effective Jun 24, 2026.
How has the price of DOVATO 50-300 MG TABLET changed over time?
Over the history we have for it, the NADAC for DOVATO 50-300 MG TABLET has risen 9.6%. It has been tracked across 125 weekly CMS publications since Feb 7, 2024.
What are the highest and lowest recorded NADAC prices for DOVATO 50-300 MG TABLET?
Since Feb 7, 2024, the NADAC for DOVATO 50-300 MG TABLET has ranged from a low of $96.0750 (Feb 7, 2024) to a high of $105.2874 (May 13, 2026), with a median of $99.9787 per EA.
Are there cheaper alternatives to DOVATO 50-300 MG TABLET?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as DOVATO 50-300 MG TABLET, but none are currently priced below it.
Who manufactures DOVATO 50-300 MG TABLET?
DOVATO 50-300 MG TABLET (NDC 49702024633) is labeled by ViiV Healthcare Company, and CMS classifies it as a brand product.
Related Drugs
Same classification